Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

[1]  D. Muthu,et al.  Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure , 2009 .

[2]  J. Cleland,et al.  Prognosis in heart failure with a normal ejection fraction. , 2007, The New England journal of medicine.

[3]  M. Hellmich,et al.  NT-pro-BNP measured at discharge predicts outcome in multimorbid diabetic inpatients with a broad spectrum of cardiovascular disease , 2007, Acta Diabetologica.

[4]  R. McKelvie,et al.  Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES. , 2007, Journal of the American College of Cardiology.

[5]  T. Hornemann,et al.  Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure* , 2006, Critical care medicine.

[6]  C Zoccali,et al.  Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. , 2006, Kidney international.

[7]  M. Picard,et al.  NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. , 2006, European heart journal.

[8]  Y. Kihara,et al.  B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. , 2006, Journal of the American College of Cardiology.

[9]  Salim Yusuf,et al.  Predictors of mortality and morbidity in patients with chronic heart failure. , 2006, European heart journal.

[10]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[11]  P. Hildebrandt,et al.  N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. , 2005, JAMA.

[12]  L. Køber,et al.  N-Terminal Pro-B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease , 2005 .

[13]  C. Camargo,et al.  The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. , 2005, The American journal of cardiology.

[14]  L. Køber,et al.  N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. , 2005, The New England journal of medicine.

[15]  Douglas W Mahoney,et al.  Diastolic dysfunction and left atrial volume: a population-based study. , 2005, Journal of the American College of Cardiology.

[16]  A. Ferreira,et al.  N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients , 2004, Circulation.

[17]  M. Quiñones,et al.  Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. , 2004, The American journal of cardiology.

[18]  A. Ahluwalia,et al.  Vascular actions of natriuretic peptides , 2004, Basic Research in Cardiology.

[19]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[20]  Douglas W Mahoney,et al.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.

[21]  James B Seward,et al.  Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. , 2002, The American journal of cardiology.

[22]  E. Traversi,et al.  Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure even when atrial fibrillation is present , 2001, European journal of heart failure.

[23]  E. J. Benjamin,et al.  Diastolic heart failure--no time to relax. , 2001, The New England journal of medicine.

[24]  T. Wakatsuki,et al.  Evaluation of left atrial filling using systolic pulmonary venous flow velocity measurements in patients with atrial fibrillation , 1998, Clinical cardiology.

[25]  D. Fukai,et al.  Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. , 1997, Circulation.

[26]  R B D'Agostino,et al.  Left atrial size and the risk of stroke and death. The Framingham Heart Study. , 1995, Circulation.

[27]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .